GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: ONCE
Buy $90
up 18.00 %

Spark Therapeutics Inc. (NASDAQ: ONCE) reiterated to Buy with price target $90 by Roth Capital

Monday,  Oct 5, 2015  11:25 AM ET by Betsy O'Brien Harrison

Roth Capital reiterated Spark Therapeutics Inc. (NASDAQ: ONCE) to Buy with price target $90. Previously Roth Capital reiterated Spark Therapeutics Inc. (NASDAQ: ONCE) to Buy with
price target $72 on 02/19/2015, when the stock price was $47.50. Since then, Spark Therapeutics Inc.'s stock price has gained 18% as of 10/05/2015's recent price of $56.15.
If you would have followed the previous Roth Capital's recommendation on ONCE, you would have gained 18% of your investment in 228 days.



ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy